Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

VKTX | Viking Therapeutics, Inc.

Index	RUT	P/E	-	EPS (ttm)	-0.91	Insider Own	5.89%	Shs Outstand	99.01M	Perf Week	-11.27%
Market Cap	1.35B	Forward P/E	-	EPS next Y	-1.02	Insider Trans	-16.33%	Shs Float	93.71M	Perf Month	-7.38%
Income	-74.10M	PEG	-	EPS next Q	-0.22	Inst Own	35.70%	Short Float / Ratio	13.78% / 5.74	Perf Quarter	-38.94%
Sales	-	P/S	-	EPS this Y	-25.80%	Inst Trans	-0.31%	Short Interest	12.91M	Perf Half Y	38.94%
Book/sh	3.90	P/B	3.41	EPS next Y	-13.30%	ROA	-33.40%	Target Price	33.80	Perf Year	333.55%
Cash/sh	3.87	P/C	3.44	EPS next 5Y	40.00%	ROE	-36.30%	52W Range	2.53 - 25.72	Perf YTD	41.60%
Dividend	-	P/FCF	-	EPS past 5Y	-2.50%	ROI	-	52W High	-48.25%	Beta	0.53
Dividend %	-	Quick Ratio	29.60	Sales past 5Y	-	Gross Margin	-	52W Low	425.15%	ATR	0.74
Employees	22	Current Ratio	29.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	37.39	Volatility	5.42% 4.89%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	14.40%	Profit Margin	-	Rel Volume	0.49	Prev Close	13.49
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Jul 26 AMC	Payout	-	Avg Volume	2.25M	Price	13.31
Recom	1.50	SMA20	-7.47%	SMA50	-8.03%	SMA200	-7.37%	Volume	1,099,159	Change	-1.33%

Date	Action	Analyst	Rating Change	Price Target Change
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14
May-05-20	Initiated	Chardan Capital Markets	Buy	$15
May-01-20	Initiated	BTIG Research	Buy	$9
Jul-16-19	Initiated	Oppenheimer	Outperform	$12
Jun-25-19	Initiated	Stifel	Buy
Mar-29-19	Upgrade	SVB Leerink	Mkt Perform → Outperform	$10 → $21
Mar-14-19	Reiterated	Maxim Group	Buy	$28 → $20
Feb-22-19	Initiated	SVB Leerink	Mkt Perform
Dec-12-18	Initiated	B. Riley FBR	Buy	$16
Nov-19-18	Upgrade	Raymond James	Outperform → Strong Buy
Sep-18-18	Reiterated	Raymond James	Outperform	$15 → $43
Sep-18-18	Reiterated	Maxim Group	Buy	$14 → $28
Sep-18-18	Reiterated	H.C. Wainwright	Buy	$15 → $28
Jul-20-18	Initiated	SunTrust	Buy	$14
Jun-28-18	Initiated	Raymond James	Outperform

Show Previous Ratings

Sep-07-23 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Sep-06-23 07:03AM	Viking Therapeutics Announces Initiation of Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity (PR Newswire)
Aug-28-23 10:22AM	15 Most Shorted Stocks That Are Loved By Analysts (Insider Monkey)
Aug-17-23 09:31AM	15 Best-Performing Stocks in the Last 12 Months (Insider Monkey)
Aug-16-23 07:07PM	The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023 (InvestorPlace)
11:45AM	Loading…
Aug-09-23 11:45AM	Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings (Zacks)
Aug-08-23 11:45AM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today (Motley Fool) +11.88%
Aug-02-23 11:15AM	2 Magnificient Growth Stocks I'm Buying in August (Motley Fool)
Jul-29-23 11:39AM	10 Oversold Biotech Stocks to Buy (Insider Monkey)
Jul-27-23 09:51AM	Q2 2023 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-26-23 04:05PM	Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
Jul-22-23 06:14AM	3 Small-Cap Stocks That Could Be Big-Time Winners (Motley Fool)
Jul-19-23 04:05PM	Viking Therapeutics to Report Financial Results for Second Quarter 2023 on July 26, 2023 (PR Newswire)
Jul-12-23 10:05AM	2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher (Motley Fool)
Jul-10-23 09:32AM	Viking Therapeutics (VKTX) Surges 64% Year to Date: Here's Why (Zacks)
09:29AM	Loading…
09:29AM	Sotherly Hotels' (SOHO) Q2 Operating Trend Reflects Solid Demand (Zacks)
Jul-07-23 06:32PM	The 3 Best Momentum Stocks to Buy in July (InvestorPlace)
08:00AM	Obesity Drugs Wont Starve These Other Potential Blockbusters (The Wall Street Journal)
Jul-05-23 08:14PM	Oppenheimer Predicts up to 140% Rally for These 3 Stocks Heres Why They Have Solid Upside (TipRanks)
Jun-29-23 02:00PM	The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 (InvestorPlace)
08:30AM	Better Buy: Nano-X Imaging vs. Viking Therapeutics (Motley Fool)
Jun-27-23 01:53PM	Why Viking Therapeutics Is Plunging Today (Motley Fool) -18.22%
Jun-26-23 11:39PM	Why Viking Therapeutics Stock Is Crashing Today (Motley Fool) -11.08%
Jun-22-23 06:40AM	3 Biotech Stocks to Buy as Companies Ink Major Deals (InvestorPlace)
Jun-20-23 10:15AM	After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy? (Motley Fool)
05:50AM	Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money. (Motley Fool)
05:25AM	If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position (Motley Fool)
Jun-17-23 09:06AM	Could Viking Therapeutics Stock Help You Become a Millionaire? (Motley Fool)
Jun-13-23 11:15AM	Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics? (Motley Fool)
Jun-12-23 10:15AM	Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years (Motley Fool)
11:14AM	Loading…
Jun-08-23 11:14AM	Top Healthcare Stocks for June 2023 (Investopedia)
10:07AM	This Red-Hot Growth Stock Has Soared 885% in Just 12 Months (Motley Fool)
Jun-07-23 07:13AM	10 Stocks Wall Street Analysts and Billionaires Are Crazy About (Insider Monkey)
May-31-23 02:49PM	Why Viking Therapeutics Stock Is Heating Up Today (Motley Fool) +6.40%
May-30-23 05:38AM	2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street (Motley Fool)
May-26-23 06:19AM	3 Biotech Stocks Sitting on Huge-Upside Catalysts (InvestorPlace)
May-24-23 11:59AM	Here's Why Hepion Pharma (HEPA) is Up More Than 80% in Two Days (Zacks)
May-22-23 12:02PM	Intercept (ICPT) NASH Treatment Fails to Get GIDAC Recommendation (Zacks) +6.01%
06:40AM	Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich or Broke. (InvestorPlace)
May-21-23 03:28PM	7 Stocks That Wall Street Analysts Are Loving in May (InvestorPlace)
May-19-23 03:27PM	Boeing, First Solar, and Viking Therapeutics Notch Stellar Performances Over the Last Year (Barrons.com)
May-18-23 02:52PM	Why Viking Therapeutics Stock Is Buckling Today (Motley Fool) -5.04%
12:12PM	Intercept (ICPT) Down Ahead of GIDAC Meeting for NASH Treatment (Zacks)
May-17-23 01:59PM	Viking (VKTX) Up 12% as VKTX-2809 Meets Goals in NASH Study (Zacks)
May-16-23 04:12PM	Top 1% Biotech Viking Yo-Yos, But Hits A Record, On NASH Enthusiasm (Investor's Business Daily) +12.07%
03:52PM	Why Viking Therapeutics Stock Bolted Higher Today (Motley Fool)
11:29AM	Top 1% Biotech Viking Therapeutics Backs Off Its Record Run On NASH Enthusiasm (Investor's Business Daily)
09:32AM	Why Top 1% Biotech Viking Therapeutics Is At The Brink Of A Record High (Investor's Business Daily)
07:31AM	UPDATE 2-Viking Therapeutics's NASH drug succeeds in mid-stage trial, shares jump (Reuters)
07:00AM	Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) (PR Newswire)
May-11-23 08:39AM	Top Healthcare Stocks for May 2023 (Investopedia)
May-09-23 03:40PM	Why Viking Therapeutics Stock Wobbled Today (Motley Fool)
May-01-23 04:28PM	Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today (Motley Fool)
Apr-27-23 02:56PM	Why Viking Therapeutics Stock Briefly Popped Today (Motley Fool)
06:31AM	Q1 2023 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-26-23 04:05PM	Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
Apr-25-23 08:45AM	3 Top Biotech Stocks Defying the Bear Market (Motley Fool) -6.80%
07:12AM	As Viking Therapeutics, Inc. (NASDAQ:VKTX) gains 8.7%, insiders who bought last year may be wishing they had bet higher (Simply Wall St.)
Apr-20-23 04:05PM	Viking Therapeutics to Report Financial Results for First Quarter 2023 on April 26, 2023 (PR Newswire)
Apr-19-23 02:42PM	Top Biotech Stocks for Q2 2023 (Investopedia)
Apr-11-23 04:05PM	Viking Therapeutics to Present at 22nd Annual Needham Healthcare Conference (PR Newswire)
Apr-07-23 06:40PM	Tillys, American Public Education Stock See Action From Activist Investors (Barrons.com)
Apr-03-23 05:06PM	Viking Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Underwriters' Option to Purchase Additional Shares (PR Newswire) +5.53%
Apr-01-23 01:43PM	5 Best Stocks to Buy in April (Motley Fool)
Mar-30-23 02:06PM	Why Shares of Viking Therapeutics Skyrocketed This Week (Motley Fool) +8.79%
01:48AM	Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock (PR Newswire)
Mar-29-23 04:10PM	Novo Hits Another Record High As WHO Considers A Key Move In Obesity (Investor's Business Daily)
04:01PM	Viking Therapeutics Announces Proposed Public Offering of Common Stock (PR Newswire)
12:51PM	The Government Move That Could Drive Obesity Drugs And Lilly, Novo Shares (Investor's Business Daily)
11:24AM	Biotech Stock Roundup: VKTX, BMEA, ITCI Soar on Study Data, INCY Faces Setback (Zacks)
07:45AM	Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run (Motley Fool)
05:54AM	Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%? (Motley Fool)
Mar-28-23 04:18PM	Viking Rockets 69% After Dropping This Scorcher In The Obesity Treatment Battle (Investor's Business Daily) +69.30%
04:18PM	Viking Rockets 63% After Dropping This Scorcher In The Obesity Treatment Battle (Investor's Business Daily)
12:32PM	Viking Therapeutics Steps Into The Obesity Ring And Catapults 63% (Investor's Business Daily)
07:03AM	Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Oral Formulation of Dual GLP-1/GIP Receptor Agonist VK2735 (PR Newswire)
07:00AM	UPDATE 2-Viking Therapeutics obesity drug shows promise in early-stage study, shares soar (Reuters)
06:33AM	Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 (PR Newswire)
Mar-27-23 05:47AM	Is Viking Therapeutics a Smart Buy on the Dip? (Motley Fool)
Mar-15-23 03:28PM	We're Not Very Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Rate (Simply Wall St.)
Mar-07-23 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Feb-23-23 10:30AM	2 Surging Healthcare Stocks That Are Still Worth Buying (Motley Fool)
Feb-11-23 07:05AM	Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-08-23 04:05PM	Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update (PR Newswire)
Feb-07-23 04:05PM	Viking Therapeutics to Present at SVB Securities Global Biopharma Conference (PR Newswire)
Feb-01-23 04:05PM	Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2022 on February 8, 2023 (PR Newswire)
Jan-12-23 06:06AM	Individual investors account for 50% of Viking Therapeutics, Inc.'s (NASDAQ:VKTX) ownership, while institutions account for 32% (Simply Wall St.)
Jan-09-23 07:05AM	Viking Therapeutics Announces Completion of Enrollment in Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) (PR Newswire)
Dec-28-22 09:29PM	12 Best 52-Week High Stocks To Buy Now (Insider Monkey) +10.85%
Dec-19-22 08:42AM	Viking Therapeutics' stock rallies after Madrigal shares positive data about its liver drug (MarketWatch) +73.88%
Dec-09-22 12:00PM	Viking Therapeutics, Inc. (VKTX) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Nov-22-22 08:30AM	My 3 Top Biotech Stock Picks for 2023 (Motley Fool)
Nov-16-22 06:01AM	A Viking Therapeutics, Inc. (NASDAQ:VKTX) insider increased their holdings by 68% last year (Simply Wall St.) -6.94%
Nov-08-22 04:05PM	Viking Therapeutics to Present at Stifel 2022 Healthcare Conference (PR Newswire)
Oct-26-22 04:05PM	Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
Oct-19-22 04:05PM	Viking Therapeutics to Report Financial Results for Third Quarter 2022 on October 26, 2022 (PR Newswire) -12.13%
Oct-06-22 03:09PM	We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth (Simply Wall St.)
Sep-15-22 11:38AM	Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon (Motley Fool)
Sep-06-22 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Aug-05-22 06:51AM	What Is The Ownership Structure Like For Viking Therapeutics, Inc. (NASDAQ:VKTX)? (Simply Wall St.) +7.86%

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rowland Charles A Jr	Director	May 16	Option Exercise	1.08	40,000	43,200	70,000	May 18 06:31 PM
MACARTNEY LAWSON	Director	May 16	Option Exercise	1.19	16,000	19,040	63,965	May 18 06:30 PM
Rowland Charles A Jr	Director	May 16	Sale	25.00	40,000	1,000,000	30,000	May 18 06:31 PM
MACARTNEY LAWSON	Director	May 16	Sale	24.00	16,000	384,000	47,965	May 18 06:30 PM
Lian Brian	President & CEO	May 01	Sale	22.45	45,000	1,010,250	2,197,963	May 01 07:03 PM
MACARTNEY LAWSON	Director	Apr 24	Option Exercise	3.33	16,000	53,280	63,965	Apr 24 07:31 PM
MACARTNEY LAWSON	Director	Apr 24	Sale	22.00	16,000	352,061	47,965	Apr 24 07:31 PM
Lian Brian	President & CEO	Apr 19	Sale	21.45	35,000	750,750	2,242,963	Apr 21 07:29 PM
Lian Brian	President & CEO	Apr 17	Option Exercise	2.15	125,000	268,750	2,432,963	Apr 18 07:09 PM
MACARTNEY LAWSON	Director	Apr 17	Option Exercise	8.00	20,786	166,288	68,751	Apr 18 07:10 PM
Mancini Marianna	Chief Operating Officer	Apr 17	Option Exercise	13.07	12,500	163,375	300,263	Apr 18 07:08 PM
ZANTE GREG	Chief Financial Officer	Apr 17	Option Exercise	13.07	7,500	98,025	156,779	Apr 18 07:07 PM
Lian Brian	President & CEO	Apr 17	Sale	20.45	155,000	3,169,766	2,277,963	Apr 18 07:09 PM
MACARTNEY LAWSON	Director	Apr 17	Sale	20.00	20,786	415,720	47,965	Apr 18 07:10 PM
Mancini Marianna	Chief Operating Officer	Apr 17	Sale	20.00	12,500	250,000	287,763	Apr 18 07:08 PM
ZANTE GREG	Chief Financial Officer	Apr 17	Sale	20.00	7,500	150,000	149,279	Apr 18 07:07 PM
Lian Brian	President & CEO	Apr 13	Option Exercise	1.88	54,336	102,152	2,387,299	Apr 13 05:14 PM
Lian Brian	President & CEO	Apr 13	Sale	18.45	79,336	1,463,749	2,307,963	Apr 13 05:14 PM
ZANTE GREG	Chief Financial Officer	Apr 12	Option Exercise	5.99	41,544	249,026	190,823	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 12	Sale	18.00	41,544	747,792	149,279	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 11	Option Exercise	5.25	56,295	295,778	205,574	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 11	Sale	18.00	56,295	1,013,518	149,279	Apr 13 05:13 PM
ZANTE GREG	Chief Financial Officer	Apr 03	Option Exercise	7.77	30,911	240,178	178,689	Apr 03 07:24 PM
ZANTE GREG	Chief Financial Officer	Apr 03	Sale	18.00	30,911	556,398	147,778	Apr 03 07:24 PM
Lian Brian	President & CEO	Apr 03	Sale	17.85	22,000	392,700	2,232,963	Apr 03 07:26 PM
Lian Brian	President & CEO	Mar 31	Option Exercise	9.49	67,970	645,035	2,322,933	Apr 03 07:26 PM
Lian Brian	President & CEO	Mar 31	Sale	17.45	67,970	1,186,076	2,254,963	Apr 03 07:26 PM
ZANTE GREG	Chief Financial Officer	Mar 30	Option Exercise	7.29	93,750	683,482	278,807	Apr 03 07:24 PM
Lian Brian	President & CEO	Mar 30	Option Exercise	2.42	135,382	327,838	2,408,345	Apr 03 07:26 PM
Mancini Marianna	Chief Operating Officer	Mar 30	Option Exercise	8.12	36,100	293,122	297,995	Apr 03 07:22 PM
Lian Brian	President & CEO	Mar 30	Sale	17.16	153,382	2,632,516	2,254,963	Apr 03 07:26 PM
ZANTE GREG	Chief Financial Officer	Mar 30	Sale	17.00	131,029	2,227,821	147,778	Apr 03 07:24 PM
Mancini Marianna	Chief Operating Officer	Mar 29	Option Exercise	9.13	15,000	136,950	303,137	Mar 30 09:04 PM
Mancini Marianna	Chief Operating Officer	Mar 29	Sale	16.00	41,242	659,872	261,895	Mar 30 09:04 PM
Mancini Marianna	Chief Operating Officer	Mar 28	Option Exercise	2.37	167,427	397,193	484,700	Mar 30 09:04 PM
Mancini Marianna	Chief Operating Officer	Mar 28	Sale	15.00	196,563	2,948,445	288,137	Mar 30 09:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX | Viking Therapeutics, Inc.

Upgrade your FINVIZ experience